Results
71,123 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 3 | Tang StanleyDirector |  DASHDoorDash, Inc.Open-market sale · 10b5-1 plan | SELL | $38K 200 sh | Nov 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $38K 200 sh | Nov 4, 2026 |
| 3 | Matsuda MasaruEVP, Chief Legal Officer |  ARQTArcutis Biotherapeutics, Inc.Option exercise · 10b5-1 plan | M | $146K 40.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 3 | Nithrakashyap ArvindDirector, Chief Technology Officer |  RBRKRubrik, Inc.Open-market sale · 10b5-1 plan | SELL | $47K 397 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 3 | Felice Laura L.EVP, Chief Financial Officer |  BJBJ's Wholesale Club Holdings, Inc.Option exercise · 10b5-1 plan | M | — 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $18K 100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Tsuchimoto Kim RDirector |  MNPRMonopar TherapeuticsOption exercise · 10b5-1 plan | M | — 856 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 3 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $36K 586 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 2 | Bealmear Richard CraigChief Financial Officer |  OKLOOklo Inc.Option exercise · 10b5-1 plan | M | $53K 16.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 2 | Kane CharlesDirector |  SYMSymbotic Inc.Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 2 | Syrvalin Kristine CEVP General Counsel |  MTUSMetallus Inc.Option exercise · 10b5-1 plan | M | $77K 4,640 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 2 | Kane CharlesDirector | SYMSymbotic Inc. Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 2 | Kane CharlesDirector | SYMSymbotic Inc. Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 2 | Reardon AndrewCLO & Secretary |  LGNDLIGAND PHARMACEUTICALS INCOption exercise · 10b5-1 plan | M | $261K 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 2 | Ghaffarian Kamal SeyedDirector, 10% Owner |  XEX-Energy, Inc.Other acquisition or disposition · 10b5-1 plan | J | — 108.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 1 | Barak MariaChief Accounting Officer |  RUNSunrun Inc.Open-market sale · 10b5-1 plan | SELL | $30K 3,256 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 1 | Santana RafaelDirector, President and CEO |  WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPOpen-market sale · 10b5-1 plan | SELL | $116K 398 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 1 | Bertolini JeffreyChief Operating Officer |  CARLCARLSMED, INC.Open-market sale · 10b5-1 plan | SELL | $11K 747 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 1 | Daunt JohnEVP, Chief Commercial Officer |  LQDTLIQUIDITY SERVICES INCOpen-market sale · 10b5-1 plan | SELL | $17K 390 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 1 | Bayview Legacy, LLC10% Owner |  AIPArteris, Inc.Open-market sale · 10b5-1 plan | SELL | $92K 4,901 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 1 | Daunt JohnEVP, Chief Commercial Officer | LQDTLIQUIDITY SERVICES INC Open-market sale · 10b5-1 plan | SELL | $15K 325 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 1 | de Verneuil VaninaEVP, General Counsel, Corp Sec |  VIRVir Biotechnology, Inc.Open-market sale · 10b5-1 plan | SELL | $27K 2,407 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 1 | Comly Barbara J.EVP, GC & Corporate Secretary |  MIAXMIAMI INTERNATIONAL HOLDINGS, INC.Option exercise · 10b5-1 plan | M | $280K 23.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 1 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $151K 526 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 1 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $87K 302 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 1 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $98K 334 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 1 | Scott JacobGENERAL COUNSEL AND CORP. SEC. |  CXMSprinklr, Inc.Open-market sale · 10b5-1 plan | SELL | $114K 16.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Krasnow ToddDirector | SYMSymbotic Inc. Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Krasnow ToddDirector | SYMSymbotic Inc. Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $50K 174 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Comly Barbara J.EVP, GC & Corporate Secretary | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Option exercise · 10b5-1 plan | M | $106K 8,799 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $14K 48 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $19K 66 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Comly Barbara J.EVP, GC & Corporate Secretary | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Option exercise · 10b5-1 plan | M | — 23.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Wassil JimEVP, Chief Scientific Ofc, COO | PCVXVaxcyte, Inc. Option exercise · 10b5-1 plan | M | — 2,250 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Bealmear Richard CraigChief Financial Officer | OKLOOklo Inc. Option exercise · 10b5-1 plan | M | $17K 5,369 sh | Nov 4, 2026 traded Nov 3, 2026 |